Literature DB >> 10098749

Thymidine phosphorylase/platelet-derived endothelial cell growth factor is upregulated in advanced solid types of gastric cancer.

T Yoshikawa1, K Suzuki, O Kobayashi, M Sairenji, H Motohashi, A Tsuburaya, Y Nakamura, A Shimizu, S Yanoma, Y Noguchi.   

Abstract

Previous studies demonstrated that the immunohistochemical expression of thymidine phosphorylase (dThdPase) was related with distant metastasis and disease progression. In this study we investigated the production of dThdPase/platelet-derived endothelial cell growth factor in gastric cancer quantitatively. In a total of 75 tumour tissues and 60 normal gastric mucosa specimens, dThdPase protein concentrations were determined by ELISA. The amount of dThdPase was significantly higher in the tumour tissue than in the normal tissue. Intratumoural dThdPase concentrations were significantly higher in Borrmann types I and II macroscopically, in poorly differentiated and solid type histologically, in the medullary type of the tumour stroma, and in the tumour-invading serosa. In the medullary type of the amount of tumour stroma, protein levels of dThdPase were positively correlated with the vertical diameter of the tumour (r = 0.580, P = 0.019). By immunohistochemical study, dThdPase expression on tumour cells was observed in all seven specimens with high dThdPase protein levels, but not in all 14 cases with low dThdPase protein levels (P < 0.05). In summary, these data indicated that dThdPase is up-regulated in advanced solid types of gastric cancer, suggesting that dThdPase production in carcinoma cells might be induced by the microenvironment.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10098749      PMCID: PMC2362246          DOI: 10.1038/sj.bjc.6690182

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  17 in total

1.  Angiogenic factor.

Authors:  T Furukawa; A Yoshimura; T Sumizawa; M Haraguchi; S Akiyama; K Fukui; M Ishizawa; Y Yamada
Journal:  Nature       Date:  1992-04-23       Impact factor: 49.962

Review 2.  Angiogenic factors.

Authors:  J Folkman; M Klagsbrun
Journal:  Science       Date:  1987-01-23       Impact factor: 47.728

3.  Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor.

Authors:  F Ishikawa; K Miyazono; U Hellman; H Drexler; C Wernstedt; K Hagiwara; K Usuki; F Takaku; W Risau; C H Heldin
Journal:  Nature       Date:  1989-04-13       Impact factor: 49.962

4.  Activation of 5'-deoxy-5-fluorouridine by thymidine phosphorylase in human tumors.

Authors:  A Kono; Y Hara; S Sugata; Y Karube; Y Matsushima; H Ishitsuka
Journal:  Chem Pharm Bull (Tokyo)       Date:  1983-01       Impact factor: 1.645

5.  Fluorinated pyrimidine nucleosides. 3. Synthesis and antitumor activity of a series of 5'-deoxy-5-fluoropyrimidine nucleosides.

Authors:  A F Cook; M J Holman; M J Kramer; P W Trown
Journal:  J Med Chem       Date:  1979-11       Impact factor: 7.446

6.  Antitumor activity of 5'-deoxy-5-fluorouridine in human digestive organ cancer xenografts and pyrimidine nucleoside phosphorylase activity in normal and neoplastic tissues from human digestive organs.

Authors:  Y Nio; H Kimura; M Tsubono; C C Tseng; K Kawabata; Y Masai; H Hayashi; C Meyer; M Fukumoto; T Tobe
Journal:  Anticancer Res       Date:  1992 Jul-Aug       Impact factor: 2.480

7.  Cytokines induce thymidine phosphorylase expression in tumor cells and make them more susceptible to 5'-deoxy-5-fluorouridine.

Authors:  H Eda; K Fujimoto; S Watanabe; M Ura; A Hino; Y Tanaka; K Wada; H Ishitsuka
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

8.  Purification and properties of an endothelial cell growth factor from human platelets.

Authors:  K Miyazono; T Okabe; A Urabe; F Takaku; C H Heldin
Journal:  J Biol Chem       Date:  1987-03-25       Impact factor: 5.157

9.  Purification and tissue distribution of human thymidine phosphorylase; high expression in lymphocytes, reticulocytes and tumors.

Authors:  A Yoshimura; Y Kuwazuru; T Furukawa; H Yoshida; K Yamada; S Akiyama
Journal:  Biochim Biophys Acta       Date:  1990-04-23

Review 10.  Platelet-derived endothelial cell growth factor thymidine phosphorylase in tumour growth and response to therapy.

Authors:  L Griffiths; I J Stratford
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

View more
  8 in total

1.  Histopathological identification of colon cancer with microsatellite instability.

Authors:  J Alexander; T Watanabe; T T Wu; A Rashid; S Li; S R Hamilton
Journal:  Am J Pathol       Date:  2001-02       Impact factor: 4.307

2.  Prognostic value of thymidine phosphorylase activity in liver tissue adjacent to hepatocellular carcinoma.

Authors:  Takahiro Ezaki; Toru Ikegami; Takashi Maeda; Tomomi Yamada; Teruyoshi Ishida; Makoto Hashizume; Yoshihiko Maehara
Journal:  Int J Clin Oncol       Date:  2005-06       Impact factor: 3.402

3.  Localization of thymidine phosphorylase in advanced gastric and colorectal cancer.

Authors:  Michiya Kobayashi; Ken Okamoto; Toyokazu Akimori; Naoshige Tochika; Tadashi Yoshimoto; Takehiro Okabayashi; Takeki Sugimoto; Keijiro Araki
Journal:  J Mol Histol       Date:  2004-01       Impact factor: 2.611

4.  Apoptosis induced by preoperative oral 5'-DFUR administration in gastric adenocarcinoma and its mechanism of action.

Authors:  Wen-He Zhao; Shi-Fu Wang; Wei Ding; Jian-Ming Sheng; Zhi-Min Ma; Li-Song Teng; Min Wang; Fu-Sheng Wu; Bing Luo
Journal:  World J Gastroenterol       Date:  2006-03-07       Impact factor: 5.742

5.  Thymidine phosphorylase in cancer cells stimulates human endothelial cell migration and invasion by the secretion of angiogenic factors.

Authors:  I V Bijnsdorp; F Capriotti; F A E Kruyt; N Losekoot; M Fukushima; A W Griffioen; V L Thijssen; G J Peters
Journal:  Br J Cancer       Date:  2011-03-08       Impact factor: 7.640

6.  Expression of thymidine phosphorylase in lymph nodes involved with mycosis fungoides and sézary syndrome.

Authors:  Xingcao Nie; Rekha Bhat; Essel Dulaimi Al-Saleem; Eric C Vonderheid; J Steve Hou
Journal:  Adv Hematol       Date:  2011-11-14

7.  Induction of thymidine phosphorylase as a pharmacodynamic end-point in patients with advanced carcinoma treated with 5-fluorouracil, folinic acid and interferon alpha.

Authors:  J P Braybrooke; D J Propper; K J O'Byrne; M I Koukourakis; A V Patterson; S Houlbrook; S D Love; S Varcoe; M Taylor; T S Ganesan; D C Talbot; A L Harris
Journal:  Br J Cancer       Date:  2000-07       Impact factor: 7.640

Review 8.  The dual role of thymidine phosphorylase in cancer development and chemotherapy.

Authors:  Annelies Bronckaers; Federico Gago; Jan Balzarini; Sandra Liekens
Journal:  Med Res Rev       Date:  2009-11       Impact factor: 12.944

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.